Studies have found that high ZFPM2-AS1 expression is an adverse prognostic factor of several cancers, such as gastric cancer 7, renal cell carcinoma 8 and lung adenocarcinoma 11. The gene discussed is ZFPM2; the disease is renal cell carcinoma.